<DOC>
	<DOC>NCT02648841</DOC>
	<brief_summary>The purpose of this study is to explore the role of adjuvant chemo-radiotherapy in patients with local advanced gastric cancer.</brief_summary>
	<brief_title>A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Gastric cancer; D2 and R0 resection; Pathologically confirmed stage anyT, N+, M0 (AJCC Cancer Staging); Karnofsky performance score (KPS) &gt;= 70 or Eastern Cooperative Oncology Group(ECOG) score 01; Adequate blood counts: White blood cell count ≥3.5 x 109/L Haemoglobin levels ≥100g/L Platelet count ≥100 x 109/L Creatinine levels ≤1.0× upper normal limit（UNL） Urea nitrogen levels ≤1.0× upper normal limit（UNL） Alanine aminotransferase(ALT) ≤1.5× upper normal limit（UNL） Aspartate aminotransferase(AST) ≤1.5× upper normal limit（UNL） Alkaline phosphatase(ALP) ≤1.5× upper normal limit（UNL） Total bilirubin(TBIL) ≤1.5× upper normal limit（UNL） No allergic history of 5Fu or Platinum drugs; No history of chemotherapy or other anticancer therapy; Informed consent should be signed. GEJ adenocarcinoma Concomitant malignancies;(except basocellular carcinoma or insitu cervical carcinoma) Allergic to Fluorouracil or Platinum drugs; Concurrent uncontrolled medical condition; Known malabsorption syndromes or lack of physical integrity of upper gastrointestinal tract; Severe postoperative complications such as anastomotic leakage, etc.; Symptoms or history of peripheral neuropathy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>adjuvant chemo-radiotherapy</keyword>
</DOC>